Cargando…

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins

Detalles Bibliográficos
Autores principales: Račkauskas, Rokas, Zhou, Dachen, Ūselis, Simonas, Strupas, Kęstutis, Herr, Ingrid, Schemmer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603549/
https://www.ncbi.nlm.nih.gov/pubmed/37830166
http://dx.doi.org/10.3892/or.2023.8646
_version_ 1785126628638064640
author Račkauskas, Rokas
Zhou, Dachen
Ūselis, Simonas
Strupas, Kęstutis
Herr, Ingrid
Schemmer, Peter
author_facet Račkauskas, Rokas
Zhou, Dachen
Ūselis, Simonas
Strupas, Kęstutis
Herr, Ingrid
Schemmer, Peter
author_sort Račkauskas, Rokas
collection PubMed
description
format Online
Article
Text
id pubmed-10603549
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-106035492023-10-28 [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins Račkauskas, Rokas Zhou, Dachen Ūselis, Simonas Strupas, Kęstutis Herr, Ingrid Schemmer, Peter Oncol Rep Corrigendum D.A. Spandidos 2023-10-11 /pmc/articles/PMC10603549/ /pubmed/37830166 http://dx.doi.org/10.3892/or.2023.8646 Text en Copyright: © Račkauskas et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Corrigendum
Račkauskas, Rokas
Zhou, Dachen
Ūselis, Simonas
Strupas, Kęstutis
Herr, Ingrid
Schemmer, Peter
[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title_full [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title_fullStr [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title_full_unstemmed [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title_short [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
title_sort [corrigendum] sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603549/
https://www.ncbi.nlm.nih.gov/pubmed/37830166
http://dx.doi.org/10.3892/or.2023.8646
work_keys_str_mv AT rackauskasrokas corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins
AT zhoudachen corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins
AT uselissimonas corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins
AT strupaskestutis corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins
AT herringrid corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins
AT schemmerpeter corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins